Filing Flows › Codexis (CDXS) › R&D spending
Codexis (CDXS) R&D spending by quarter
Codexis' R&D spending was $11.7M in Q2 2026 (second quarter 2026), +2% from Q1 2026. Over the last 7 quarters it ranged from $11.4M (Q1 2026) to $13.9M (Q3 2025).
| Quarter | R&D spending | Q/Q | Y/Y |
|---|---|---|---|
| Q2 2026 | $11.7M | +2% | -15% |
| Q1 2026 | $11.4M | -2% | -12% |
| Q4 2025 | $11.7M | -15% | -3% |
| Q3 2025 | $13.9M | +0.7% | — |
| Q2 2025 | $13.8M | +6% | — |
| Q1 2025 | $12.9M | +7% | — |
| Q4 2024 | $12.1M | — | — |
Q2 2026 at a glance
Codexis, Q2 2026: revenue $14.9M (-3% year over year), operating margin -75.3%, net loss $12.0M, operating cash flow −$9.6M. The chart follows the revenue to costs, profit and cash.
Questions
What is Codexis' R&D spending?
Codexis' R&D spending was $11.7M in Q2 2026 (second quarter 2026), +2% from Q1 2026.
How has Codexis' R&D spending changed?
Over the last 7 quarters it ranged from $11.4M (Q1 2026) to $13.9M (Q3 2025).